ProKidney Corp.(PROK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PROK ProKidney Corp.

盘前交易 02-04 06:24:39 EST

2.03

-0.01

-0.49%

最高2.09	最低1.88	成交量216.92万
今开2.02	昨收2.04	日振幅10.10%
总市值6.11亿	流通市值5.57亿	总股本3.01亿
成交额431.75万	换手率0.79%	流通股本2.74亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PROK","market":"US","secType":"STK","nameCN":"ProKidney Corp.","latestPrice":2.03,"timestamp":1770152400000,"preClose":2.04,"halted":0,"volume":2169160,"delay":0,"changeRate":-0.004901960784313838,"floatShares":274159714,"shares":300834400,"eps":-0.543298,"marketStatus":"盘前交易","change":-0.01,"latestTime":"02-04 06:24:39 EST","open":2.02,"high":2.09,"low":1.884,"amount":4317474.806232,"amplitude":0.10098,"askPrice":2.25,"askSize":100,"bidPrice":1.73,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.543298,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770215400000},"marketStatusCode":1,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":2.03,"postHourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.03,"latestTime":"19:47 EST","volume":3539,"amount":7204.764,"timestamp":1770166027281,"change":0.02,"changeRate":0.009852,"amplitude":0.03399},"volumeRatio":2.3944837499169878,"impliedVol":4.5373,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/PROK","defaultTab":"news","newsList":[{"id":"2605736122","title":"Prokidney Corp.盘中异动 早盘股价大跌5.24%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605736122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605736122?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:32","pubTimestamp":1768919576,"startTime":"0","endTime":"0","summary":"北京时间2026年01月20日22时32分，Prokidney Corp.股票出现异动，股价急速下跌5.24%。截至发稿，该股报2.17美元/股，成交量11.7402万股，换手率0.08%，振幅0.44%。Prokidney Corp.股票所在的生物技术行业中，整体跌幅为1.25%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012022325697a29ea0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012022325697a29ea0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2583519389","title":"Prokidney Corp.盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583519389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583519389?lang=zh_cn&edition=full","pubTime":"2025-11-13 22:31","pubTimestamp":1763044277,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日22时31分，Prokidney Corp.股票出现异动，股价大幅下挫5.22%。截至发稿，该股报2.54美元/股，成交量3.5726万股，换手率0.03%，振幅2.99%。Prokidney Corp.股票所在的生物技术行业中，整体跌幅为0.20%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113223117a49f45e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113223117a49f45e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"1180464821","title":"ProKidney在2025年美国肾脏病学会肾脏周周会发布Rilparencel的第二阶段Regen-007试验的完整结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1180464821","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180464821?lang=zh_cn&edition=full","pubTime":"2025-11-07 00:01","pubTimestamp":1762444882,"startTime":"0","endTime":"0","summary":"ProKidney在2025年美国肾脏病学会肾脏周周会发布Rilparencel的第二阶段Regen-007试验的完整结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2577689919","title":"Prokidney Corp.盘中异动 急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577689919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577689919?lang=zh_cn&edition=full","pubTime":"2025-10-21 00:06","pubTimestamp":1760976377,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日00时06分，Prokidney Corp.股票出现异动，股价急速拉升5.05%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.48%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021000617a46a89fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021000617a46a89fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2575227276","title":"Prokidney Corp.盘中异动 股价大涨5.02%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575227276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575227276?lang=zh_cn&edition=full","pubTime":"2025-10-15 00:58","pubTimestamp":1760461124,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日00时58分，Prokidney Corp.股票出现异动，股价急速拉升5.02%。截至发稿，该股报3.14美元/股，成交量81.8042万股，换手率0.61%，振幅8.53%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.50%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015005845972de2cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015005845972de2cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2575216677","title":"Prokidney Corp.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575216677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575216677?lang=zh_cn&edition=full","pubTime":"2025-10-13 23:01","pubTimestamp":1760367712,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日23时01分，Prokidney Corp.股票出现异动，股价急速跳水5.30%。截至发稿，该股报2.86美元/股，成交量38.8502万股，换手率0.29%，振幅5.13%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.51%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101323015294c6bf1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101323015294c6bf1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2572784245","title":"Prokidney Corp.盘中异动 大幅拉升5.00%报2.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572784245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572784245?lang=zh_cn&edition=full","pubTime":"2025-10-02 21:59","pubTimestamp":1759413562,"startTime":"0","endTime":"0","summary":"北京时间2025年10月02日21时59分，Prokidney Corp.股票出现波动，股价大幅拉升5.00%。截至发稿，该股报2.73美元/股，成交量12.5475万股，换手率0.09%，振幅3.85%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.63%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002215922971d4b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251002215922971d4b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2558266908","title":"Prokidney Corp.盘中异动 早盘股价大跌5.02%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558266908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558266908?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:09","pubTimestamp":1754924988,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时09分，Prokidney Corp.股票出现波动，股价快速下跌5.02%。截至发稿，该股报2.46美元/股，成交量53.8707万股，换手率0.40%，振幅4.63%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.35%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811230948a4823b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811230948a4823b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2557989095","title":"Prokidney Corp.盘中异动 下午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557989095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557989095?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:28","pubTimestamp":1754587735,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时28分，Prokidney Corp.股票出现波动，股价大幅跳水5.03%。截至发稿，该股报2.74美元/股，成交量145.208万股，换手率1.09%，振幅8.37%。Prokidney Corp.股票所在的生物技术行业中，整体跌幅为0.22%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段的生物技术公司，拥有变革性的专有细胞治疗平台，能够使用从患者身上分离出来的用于治疗细胞来治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080801285594d5f913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080801285594d5f913&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2518203689","title":"Prokidney Corp.盘中异动 快速下挫5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518203689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518203689?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:16","pubTimestamp":1741623419,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时16分，Prokidney Corp.股票出现波动，股价大幅下挫5.71%。截至发稿，该股报0.990美元/股，成交量12.3953万股，换手率0.10%，振幅5.71%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.43%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311001700abf337ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311001700abf337ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2516707176","title":"Prokidney Corp.盘中异动 股价大跌5.02%报1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516707176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516707176?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:59","pubTimestamp":1741100369,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时59分，Prokidney Corp.股票出现异动，股价急速下挫5.02%。截至发稿，该股报1.04美元/股，成交量11.0811万股，换手率0.09%，振幅4.57%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.36%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422592996394d1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422592996394d1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2516634041","title":"Prokidney Corp.盘中异动 股价大涨6.93%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634041?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012293,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Prokidney Corp.股票出现异动，股价急速上涨6.93%。截至发稿，该股报1.32美元/股，成交量1.3496万股，换手率0.01%，振幅0.81%。Prokidney Corp.股票所在的生物技术行业中，整体跌幅为0.21%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032231339637abd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032231339637abd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2514863958","title":"Prokidney Corp.盘中异动 急速下挫5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514863958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514863958?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:35","pubTimestamp":1740587709,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时35分，Prokidney Corp.股票出现波动，股价急速跳水5.48%。截至发稿，该股报1.38美元/股，成交量20.9026万股，换手率0.16%，振幅5.48%。Prokidney Corp.股票所在的生物技术行业中，整体跌幅为0.05%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003509a25513b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003509a25513b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2514190740","title":"Prokidney Corp.盘中异动 早盘急速下挫5.33%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514190740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514190740?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:15","pubTimestamp":1740500155,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时15分，Prokidney Corp.股票出现波动，股价急速下挫5.33%。截至发稿，该股报1.42美元/股，成交量9.0315万股，换手率0.07%，振幅6.00%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.61%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001555a2539ef2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001555a2539ef2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2512196453","title":"Prokidney Corp.盘中异动 股价大跌5.28%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512196453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512196453?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:13","pubTimestamp":1739905995,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时13分，Prokidney Corp.股票出现波动，股价快速跳水5.28%。截至发稿，该股报1.53美元/股，成交量8.5347万股，换手率0.07%，振幅6.83%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.97%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031315abd3e8f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031315abd3e8f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2511577356","title":"Prokidney Corp.盘中异动 临近收盘急速上涨5.19%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511577356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511577356?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:46","pubTimestamp":1739479610,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时46分，Prokidney Corp.股票出现异动，股价急速上涨5.19%。截至发稿，该股报1.62美元/股，成交量25.3447万股，换手率0.20%，振幅5.84%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为1.21%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214044650abcdfbb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214044650abcdfbb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2509219397","title":"Prokidney Corp.盘中异动 股价大跌5.12%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509219397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509219397?lang=zh_cn&edition=full","pubTime":"2025-02-08 01:04","pubTimestamp":1738947895,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日01时04分，Prokidney Corp.股票出现波动，股价急速跳水5.12%。截至发稿，该股报1.58美元/股，成交量9.93万股，换手率0.08%，振幅4.82%。Prokidney Corp.股票所在的生物技术行业中，整体跌幅为0.53%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208010455abc64bd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208010455abc64bd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2509280081","title":"Prokidney Corp.盘中异动 早盘大幅上涨5.06%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509280081?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:13","pubTimestamp":1738768411,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时13分，Prokidney Corp.股票出现异动，股价大幅上涨5.06%。截至发稿，该股报1.66美元/股，成交量2.2842万股，换手率0.02%，振幅3.80%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为1.18%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231331987b83b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231331987b83b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2508468866","title":"Prokidney Corp.盘中异动 股价大涨5.16%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508468866?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:49","pubTimestamp":1738680547,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时49分，Prokidney Corp.股票出现异动，股价快速拉升5.16%。截至发稿，该股报1.63美元/股，成交量4.0551万股，换手率0.03%，振幅4.52%。Prokidney Corp.股票所在的生物技术行业中，整体涨幅为0.59%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。REACT 有可能减缓和稳定慢性肾病的进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224907987a4d73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224907987a4d73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2508124354","title":"Prokidney Corp.盘中异动 下午盘大幅跳水5.45%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508124354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508124354?lang=zh_cn&edition=full","pubTime":"2025-02-04 02:09","pubTimestamp":1738606166,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日02时09分，Prokidney Corp.股票出现异动，股价快速跳水5.45%。Prokidney Corp.股票所在的生物技术行业中，整体跌幅为0.57%。Prokidney Corp.公司简介：ProKidney Corp 是一家临床阶段生物技术公司，它拥有一个变革性的专有细胞疗法平台，能够利用从患者身上分离出来的自体细胞治疗多种慢性肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020402092698798d9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020402092698798d9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PROK","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prokidney.com","stockEarnings":[{"period":"1week","weight":-0.0814},{"period":"1month","weight":-0.0897},{"period":"3month","weight":-0.2481},{"period":"6month","weight":-0.2086},{"period":"1year","weight":0.3097},{"period":"ytd","weight":-0.0938}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProKidney Corp.是一家于2021年2月25日根据开曼群岛法律注册成立的新公司。该公司是通过细胞疗法创新治疗慢性肾病(CKD)的先驱。该公司的主要候选产品REACT（肾自体细胞疗法）是一种首创的专利疾病修饰自体细胞疗法，不仅有可能减缓和稳定CKD的进展，而且在某些情况下还能推动肾功能的显著改善。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.022112},{"month":2,"riseRate":0.8,"avgChangeRate":0.027971},{"month":3,"riseRate":0.5,"avgChangeRate":-0.077784},{"month":4,"riseRate":0.5,"avgChangeRate":0.025444},{"month":5,"riseRate":0.75,"avgChangeRate":0.19736},{"month":6,"riseRate":0.25,"avgChangeRate":-0.136783},{"month":7,"riseRate":0.4,"avgChangeRate":0.747675},{"month":8,"riseRate":0.2,"avgChangeRate":-0.09753},{"month":9,"riseRate":0.4,"avgChangeRate":-0.139421},{"month":10,"riseRate":0.6,"avgChangeRate":-0.082174},{"month":11,"riseRate":0.4,"avgChangeRate":-0.019735},{"month":12,"riseRate":0.6,"avgChangeRate":-0.066082}],"exchange":"NASDAQ","name":"ProKidney Corp.","nameEN":"ProKidney Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProKidney Corp.(PROK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProKidney Corp.(PROK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProKidney Corp.,PROK,ProKidney Corp.股票,ProKidney Corp.股票老虎,ProKidney Corp.股票老虎国际,ProKidney Corp.行情,ProKidney Corp.股票行情,ProKidney Corp.股价,ProKidney Corp.股市,ProKidney Corp.股票价格,ProKidney Corp.股票交易,ProKidney Corp.股票购买,ProKidney Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProKidney Corp.(PROK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProKidney Corp.(PROK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}